Metabolic Disorder Clinical Trial
Official title:
A Multidimensional Lifestyle Intervention to Reduce the Risk of Metabolic Disorders in Older Workers in Taiwan
The study was aimed to evaluate the effectiveness of a multidimensional worksite intervention program to reduce the severity of metabolic disorders in older workers in Taiwan.
The investigators conducted a quasi-experiment in older workers from three worksites in
southern Taiwan.
- Qualified subjects were assigned to the intervention or the reference group according
to their availability to take part in study activities.
- A researcher reviewed the health record and discussed with the subject about his/her
health status.
- Subjects in the intervention group received lifestyle interventions. The activities
included motivational presentations to increase awareness of own health problems and
the role of lifestyle in the etiology of non-communicable chronic diseases.
- Subjects were organized into small groups to have biweekly meetings to share
experiences, stimulate mutual encouragement and to overcome obstacles.
- Anthropometric and biochemical indicators were measured at baseline and endpoint (week
24).
;
Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Health Services Research
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00546052 -
A 52 Week Study to Evaluate the Effects of Losartan With or Without HCTZ on Plasma Glucose, Metabolic Parameters, Blood Pressure in Hypertensive Patients With Metabolic Syndrome (0954A-331)
|
Phase 3 | |
| Completed |
NCT02650674 -
Determination of the Glycaemic Index and Insulinaemic Index Values of Five Cereal Products
|
N/A | |
| Completed |
NCT00707746 -
Safety and Efficacy Study of ISIS 301012 (Mipomersen) Administration in High Risk Statin Intolerant Subjects
|
Phase 2 | |
| Completed |
NCT02573103 -
Air Pollution and Cardiovascular Disease
|
||
| Not yet recruiting |
NCT06051461 -
Deciphering the Role of Dietary Fatty Acids on Extracellular Vesicles-mediated Intercellular Communication
|
N/A | |
| Not yet recruiting |
NCT05013112 -
Ameliorating Metabolic Profiling After Kidney Transplantation (AMPKT)
|
N/A | |
| Enrolling by invitation |
NCT04654000 -
Rheopheresis as Adjuvant Treatment of Calciphylaxis
|
N/A | |
| Completed |
NCT01337141 -
A Telematic Program for Optimization of Metabolic Control in Diabetes Mellitus Type 1 (DM1) Patients
|
N/A | |
| Completed |
NCT00477594 -
Open Label Extension of ISIS 301012 (Mipomersen) to Treat Familial Hypercholesterolemia
|
Phase 2 | |
| Recruiting |
NCT03882580 -
Reporting, Evaluating, Preventing and Treating the Cardiotoxicity Induced by Anticancer Drugs During a Specific Cardio-oncology Consult and Follow up in Routine Care
|
||
| Active, not recruiting |
NCT01911091 -
Identification of Novel Skeletal Muscle-derived Factors That Promote Lipid Oxidation (Columbus)
|
N/A | |
| Completed |
NCT00607373 -
Study to Assess the Safety and Efficacy of ISIS 301012 (Mipomersen) in Homozygous Familial Hypercholesterolemia
|
Phase 3 | |
| Completed |
NCT00362180 -
Measure Liver Fat Content After ISIS 301012 (Mipomersen) Administration
|
Phase 2 | |
| Completed |
NCT03873948 -
Evaluation of Arginine in Periodontal and Cardiovascular Disease
|
||
| Completed |
NCT02059993 -
The Effects of Obstructive Sleep Apnea and Its Intervention on Coronary Heart Disease
|
N/A | |
| Completed |
NCT06129578 -
Plant Protein Supplementation Within a Healthy Lifestyle Modulates Plasma Circulating Amino Acids and Improves the Health Status of Overweight Individuals
|
N/A | |
| Completed |
NCT06331572 -
Exploring Blood Plasma Metabolomics: Unraveling the Metabolic Landscape in Treatment-Resistant Adolescent Depression
|
||
| Completed |
NCT05255718 -
Impact of Aronia Berry Consumption on Inflammation, Metabolites, and the Gut Microbiome
|
N/A | |
| Completed |
NCT00694109 -
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
|
Phase 3 |